Stocks April 6, 2022 Stock Upgrades and Downgrades for Q1 2022 by pnik Barrington Research Initiated Helios Technologies (HLIO) at Outperform and a price target at $107
Wall Street October 15, 2013 Bind Therapeutics BIND Price Targets by erevnon.com Bind Therapeutics BIND Price Targets: • Credit Suisse starts the shares at Outperform. Price target is $21. • Cowen initiates at Outperform with a $30 price target. • Stifel starts BIND at Buy. Price target […]